# Cannabis Doctor Investigates THC and Peptides Like Semaglutide > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/polypharmacy-metabolic-health-thc-peptides-study/ > **Published:** 2026-04-10T10:29:11-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:26:04-04:00 > **Clinical Summary:** Explore polypharmacy metabolic health focusing on THC and peptides like semaglutide, highlighting clinical relevance and drug interaction insights. --- ✦ New CED Clinical Relevance  #80High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News  |  CED Clinic PolypharmacyMetabolic HealthGlp-1 AgonistsThcDrug Interactions Why This Matters This represents an emerging area of polypharmacy research that could significantly impact metabolic and [weight management](https://cedclinic.com/cannabis-metabolism-weight-management-science/) protocols in [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/). Understanding potential interactions between THC and GLP-1 receptor agonists is clinically relevant given the widespread use of both therapeutics and their opposing effects on appetite regulation. Clinical Summary A cannabis physician is proposing to study the combined effects of THC with peptide medications like semaglutide (Ozempic/Wegovy). This represents an intersection of two significant therapeutic areas: [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) and GLP-1 receptor agonists used for diabetes and [weight management](https://cedclinic.com/cannabis-metabolism-weight-management-science/). THC typically increases appetite through CB1 receptor activation, while semaglutide reduces appetite by mimicking incretin hormones. The pharmacological interaction profile, safety considerations, and clinical outcomes of combining these agents remain unstudied in formal [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/). Dr. Caplan’s Take “This is exactly the kind of real-world combination we’re seeing in practice but have zero evidence to guide us on. We need systematic data on how these opposing appetite mechanisms interact before we can make informed clinical recommendations.” Clinical Perspective 🧠 Clinicians should exercise caution when patients are using both cannabis and GLP-1 agonists, monitoring for unexpected effects on appetite, weight, and glycemic control. Document any observed interactions and consider timing of administration. Until formal studies exist, clinical decisions should be individualized with careful monitoring and patient education about the theoretical opposing mechanisms. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Cannabis%20doctor%20Looking%20to%20Study%20The%20Effects%20Of%20THC%20%2B%20Various%20Peptides%20like%20Semg...%20%40drcaplan&url=https%3A//www.reddit.com/r/Biohackers/comments/1shid39/cannabis_doctor_looking_to_study_the_effects_of/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.reddit.com/r/Biohackers/comments/1shid39/cannabis_doctor_looking_to_study_the_effects_of/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Cannabis%20doctor%20Looking%20to%20Study%20The%20Effects%20Of%20THC%20%2B%20Various%20Peptides%20like%20Semg...%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.reddit.com/r/Biohackers/comments/1shid39/cannabis_doctor_looking_to_study_the_effects_of/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.reddit.com/r/Biohackers/comments/1shid39/cannabis_doctor_looking_to_study_the_effects_of/](https://www.reddit.com/r/Biohackers/comments/1shid39/cannabis_doctor_looking_to_study_the_effects_of/) Table of Contents - [FAQ](#FAQ)[What is polypharmacy and why is it clinically relevant?](#What_is_polypharmacy_and_why_is_it_clinically_relevant) - [How do GLP-1 agonists affect metabolic health?](#How_do_GLP-1_agonists_affect_metabolic_health) - [What are the potential interactions between THC and other medications?](#What_are_the_potential_interactions_between_THC_and_other_medications) - [Why is this topic considered high clinical relevance?](#Why_is_this_topic_considered_high_clinical_relevance) - [What should patients know about combining cannabis with prescription medications?](#What_should_patients_know_about_combining_cannabis_with_prescription_medications) - [Related](#Related) ## FAQ #### What is polypharmacy and why is it clinically relevant? Polypharmacy refers to the use of multiple medications simultaneously by a patient, typically five or more drugs. It increases the risk of drug interactions, adverse effects, and medication adherence issues, making careful management essential for patient safety. #### How do GLP-1 agonists affect metabolic health? GLP-1 agonists are medications that help regulate blood sugar levels and promote weight loss by mimicking hormones that control insulin release and appetite. They have shown significant benefits for diabetes management and cardiovascular health outcomes. #### What are the potential interactions between THC and other medications? THC can interact with various medications by affecting liver enzymes that metabolize drugs, potentially altering their effectiveness or increasing side effects. Patients using cannabis should inform their healthcare providers about all medications to avoid dangerous interactions. #### Why is this topic considered high clinical relevance? This topic has strong evidence and direct clinical implications for [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/), particularly regarding drug interactions and treatment outcomes. Healthcare providers need this information to make informed prescribing decisions and ensure patient safety. #### What should patients know about combining cannabis with prescription medications? Patients should always consult their healthcare provider before combining cannabis with prescription drugs, especially metabolic medications like GLP-1 agonists. Proper monitoring and dosage adjustments may be necessary to maintain therapeutic effectiveness and prevent adverse reactions. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [High-Risk Behavior? What Your Patients Should Know About Cannabis and Diabetes](https://cedclinic.com/cannabis-and-diabetes-management-patient-safety-guide/) This article discusses the risks and considerations for patients using cannabis alongside diabetes medications, highlighting important clinical insights. [Read More](https://cedclinic.com/cannabis-and-diabetes-management-patient-safety-guide/) [Study: CBD May Increase THC Levels in Blood When Cannabis Is Vaporized](https://cedclinic.com/cbd-thc-vaporization-interaction-increases-thc-blood-levels/) Research findings on how CBD influences THC blood levels, relevant for understanding drug interactions in cannabis polypharmacy. [Explore Study](https://cedclinic.com/cbd-thc-vaporization-interaction-increases-thc-blood-levels/) [WSU Study Looks at Cannabis Impacts on Memory](https://cedclinic.com/cannabis-memory-cognitive-effects-wsu-study/) A detailed study examining how cannabis affects cognitive functions, providing context for clinical considerations in [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/). [Watch Now](https://cedclinic.com/cannabis-memory-cognitive-effects-wsu-study/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).